期刊文献+

肝细胞癌组织中泛素、P27蛋白表达及两者与临床病理分级的关系

Expression of ubiquitin and P27 protein in hepatocellular carcinoma and its clinicopathologic significance
下载PDF
导出
摘要 目的研究人肝细胞癌组织中泛素(ubiquitin)蛋白表达对P27蛋白表达的影响,及两者与肝细胞癌不同病理分级的关系及临床意义。方法采用免疫组织化学法结合蛋白免疫印迹技术,分别检测人肝细胞癌组织不同病理分级中泛素、P27蛋白的表达情况,分析人肝细胞癌组织中泛素、P27蛋白的不同表达情况与临床病理分级之间的相关性。结果肝细胞癌组织中均有泛素、P27蛋白的表达,泛素蛋白定位于细胞核及细胞质,其表达量随分化程度降低反而增高(P<0.05),P27蛋白主要定位于细胞核,其表达量随分化程度降低而降低(P<0.05)。泛素和P27蛋白的表达与病理分级有明显的相关性(P<0.05)。结论泛素蛋白高表达在P27蛋白降解过程中发挥重要作用,并与肝细胞癌的恶性程度、疾病进展有密切的关系。 Objective To study the expression of ubiquitin and P27 protein in hepatocellular carcinoma and its relationship with the different elinicopathologie degrees. Methods Immunohistochemical method and Western blot were used to detect the expression of ubiquitin and P27 protein in hepatocellular carcinoma with different elinicopathologie degrees. Relationship of the expression of ubiquitin and P27 protein in hepatocellular carcinoma with the different clinicopathologie degrees was analyzed. Results The ubiquitin and P27 protein were expressed in hepatocellular carcinoma. Ubiquitin protein was located in nuclei and/or cytoplasm, while P27 protein was mainly located in nuclei. Ubiquitin protein expression was negatively correlated with different clinicopathologic degrees in hepatoeellnlar carcinoma ( P 〈 0.05 ). P27 protein expression was positively correlated with different clinicopathologic degrees in hepatocellular carcinoma(P 〈 0.05). Conclusion The higher expression of ubiquitin protein plays an important role in the degradation of P27 protein. The ubiquitin expression and P27 protein expression are closely related to the degree of malignancy and disease progression of human hepatocellular carcinoma.
出处 《山西医科大学学报》 CAS 2010年第2期116-119,186,共5页 Journal of Shanxi Medical University
基金 陕西省自然科学基金资助项目(2008K09-05)
关键词 肝细胞癌 泛素 P27 免疫组织化学 蛋白免疫印迹 hepatocellular carcinoma ubiquitin P27 immunohistochemistry Western blot
  • 相关文献

参考文献14

  • 1Hochstrasser M. Ubiquitin protesaomes and the regulation of intracellular protein degradation [ J ]. Curr Opin Cell Biol, 1995,7 : 215.
  • 2Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin proteasome system by protein aggregation[ J]. Science,2001,292 (5521) :1467 - 1468.
  • 3Haglund K, Dikic I. Ubiquitylation and cell signaling[ J ]. EMBO J ,2005,24 (19) :3353 - 3359.
  • 4Devoy A, Soane T, Welchman R, et al. The ubiquitin proteasome system and cancer[J]. Essays Biochem,2005 ,41:187 -203.
  • 5Adams J. The development of proteasome inhibitors as anticancer drugs[ J ]. Cancer Cell ,2004,5:417 - 421.
  • 6De Salle LM, Pagano M. Regulation of the G1 to S transition by the ubiquitin pathway [ J ]. FEBS Lett, 2001,490 : 179 - 189.
  • 7Nath N, Wang S, Betts V, et al. Apoptotic and mitogenic stimuli inactivate Rb by differentiation utilization of p38 and cyclin dependent kinases [ J ]. Oncogene ,2003,22:5986 - 5994.
  • 8Bryia V, Pachemic J, Faldikova L, et al. The role of p27 ( Kipl ) in maintaining the levels of D-type cyclins in vivo[ J]. Biochim Biophys Acta,2004,1691 : 105 - 116.
  • 9Sunga C,Tae WK, Shivendra V. Ginsenoside rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15Ink4B and p27^kip1-dependent inhibition of cyclin-dependent kinases[ J]. Pharm Res,2009,26(10) :2280 -2288.
  • 10Shimizu T, Takahashi N, Taehibana K, et al. Complex regulation of CDK2 and G1 arrest during neuronal differentiation of human prostatic cancer TSU-Prl cells by staurosporine [ J ]. Antieaneer Res,2001,21 (2A) :893 - 898.

二级参考文献8

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 2邹琼,朱道奇,章宗籍,申丽娟.肝癌及癌前病变中p27蛋白和mRNA的表达[J].中国肿瘤,2005,14(1):49-52. 被引量:3
  • 3LEI P P,ZHANG Z J,SHEN L J,et al. Expression and hypermethylation of p27 kipl in hepatocarcinogenesis [J]. World J Gastroenterol,2005,11(29) :4587 - 4591.
  • 4DEVOY A, SOANE T, WELCHMAN R, et al. The ubiquitin-proteasome system and cancer [J]. Essays Biochem, 2005,41 : 187 - 203.
  • 5UNGERMANNOVA D, GAO Y, LIU X. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2 [J]. J Biol Chem, 2005,280(34) : 30301 - 30309.
  • 6OHASHII R, GAO C, MIYAZAKIi M, et al. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas [ J ]. Anticancer Res, 2001,21 ( 1B ) : 657 - 662.
  • 7TRAUB F,MENGEL M,LUCK H J, et al. Prognostic impact of Skp2 and p27 in human breast cancer[J]. Breast Cancer Res Treat, 2006,99(2) : 185 - 191.
  • 8NELSEN C J, HANSEN L K, RICKHEIM D G, et al. Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2 [J]. Oncogene, 2001,20( 15 ) : 1825 - 1831.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部